15-40740184-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018145.3(RMDN3):āc.920A>Cā(p.Glu307Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,610,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018145.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RMDN3 | NM_018145.3 | c.920A>C | p.Glu307Ala | missense_variant | 7/13 | ENST00000338376.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RMDN3 | ENST00000338376.8 | c.920A>C | p.Glu307Ala | missense_variant | 7/13 | 1 | NM_018145.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000842 AC: 21AN: 249536Hom.: 0 AF XY: 0.0000890 AC XY: 12AN XY: 134808
GnomAD4 exome AF: 0.000152 AC: 222AN: 1458166Hom.: 0 Cov.: 29 AF XY: 0.000150 AC XY: 109AN XY: 725412
GnomAD4 genome AF: 0.000151 AC: 23AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | The c.920A>C (p.E307A) alteration is located in exon 7 (coding exon 6) of the RMDN3 gene. This alteration results from a A to C substitution at nucleotide position 920, causing the glutamic acid (E) at amino acid position 307 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at